International Conference on Glomerular Diseases and Clinical Research
ICGDCR
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track will explore the latest advancements in diagnostic techniques for glomerular diseases. Emphasis will be placed on novel biomarkers and imaging modalities that enhance early detection and accurate diagnosis.
SDG 3
SDG 4
This session will delve into the underlying mechanisms of glomerular diseases, focusing on cellular and molecular pathways. Discussions will include the role of inflammation, immune response, and genetic factors in disease progression.
SDG 3
SDG 9
This track will address contemporary strategies for the clinical management of glomerulonephritis. Topics will include treatment protocols, patient monitoring, and the integration of multidisciplinary approaches in care.
SDG 3
SDG 4
This session will highlight the significance of renal biomarkers in the diagnosis and management of kidney diseases. Participants will explore the utility of biomarkers in predicting disease progression and treatment response.
SDG 3
SDG 9
This track will focus on methodologies for assessing kidney function and strategies for its preservation in patients with glomerular diseases. Emphasis will be placed on lifestyle interventions and pharmacological approaches.
SDG 3
SDG 4
This session will review cutting-edge therapeutic options for glomerular diseases, including novel pharmacological agents and biologics. Discussions will encompass clinical trial outcomes and future directions in nephrology.
SDG 3
SDG 9
This track will examine the importance of patient-centered care in the management of kidney diseases. Topics will include shared decision-making, patient education, and the psychosocial aspects of living with renal conditions.
SDG 3
SDG 10
This session will address the epidemiological trends of glomerular diseases and their public health implications. Participants will discuss risk factors, prevention strategies, and the impact of kidney disease on population health.
SDG 3
SDG 10
This track will focus on the latest developments in renal pathology, including histopathological techniques and their relevance to clinical practice. Emphasis will be placed on the correlation between pathology findings and clinical outcomes.
SDG 3
SDG 9
This session will explore the unique challenges faced in the diagnosis and management of glomerular diseases in pediatric populations. Innovative approaches to treatment and care will be discussed.
SDG 3
SDG 10
This track will provide insights into global initiatives and collaborations aimed at improving kidney health. Discussions will focus on disparities in care, access to treatment, and the role of international research partnerships.
SDG 3
SDG 10